147 related articles for article (PubMed ID: 23281253)
1. Proteomic approach toward personalized sarcoma treatment: lessons from prognostic biomarker discovery in gastrointestinal stromal tumor.
Kondo T; Suehara Y; Kikuta K; Kubota D; Tajima T; Mukaihara K; Ichikawa H; Kawai A
Proteomics Clin Appl; 2013 Jan; 7(1-2):70-8. PubMed ID: 23281253
[TBL] [Abstract][Full Text] [Related]
2. [Biomarker development by cancer proteomics].
Kondo T
Nihon Rinsho; 2012 May; 70(5):754-8. PubMed ID: 22619997
[TBL] [Abstract][Full Text] [Related]
3. [Proteomics for biomarker development toward personalized medicine].
Kondo T
Rinsho Byori; 2012 Jul; 60(7):644-9. PubMed ID: 22973724
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of pfetin: a validation study in gastrointestinal stromal tumors using a commercially available antibody.
Kubota D; Mukaihara K; Yoshida A; Suehara Y; Saito T; Okubo T; Gotoh M; Orita H; Tsuda H; Kaneko K; Kawai A; Kondo T; Sato K; Yao T
Jpn J Clin Oncol; 2013 Jun; 43(6):669-75. PubMed ID: 23619989
[TBL] [Abstract][Full Text] [Related]
5. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.
Suehara Y; Kondo T; Seki K; Shibata T; Fujii K; Gotoh M; Hasegawa T; Shimada Y; Sasako M; Shimoda T; Kurosawa H; Beppu Y; Kawai A; Hirohashi S
Clin Cancer Res; 2008 Mar; 14(6):1707-17. PubMed ID: 18347171
[TBL] [Abstract][Full Text] [Related]
6. Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor.
Hasegawa T; Asanuma H; Ogino J; Hirohashi Y; Shinomura Y; Iwaki H; Kikuchi H; Kondo T
Hum Pathol; 2013 Jul; 44(7):1271-7. PubMed ID: 23290008
[TBL] [Abstract][Full Text] [Related]
7. Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors.
Smith SM; Coleman J; Bridge JA; Iwenofu OH
J Surg Oncol; 2015 Apr; 111(5):520-31. PubMed ID: 25772665
[TBL] [Abstract][Full Text] [Related]
8. Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour.
Kubota D; Okubo T; Saito T; Suehara Y; Yoshida A; Kikuta K; Tsuda H; Katai H; Shimada Y; Kaneko K; Kawai A; Kondo T
Jpn J Clin Oncol; 2012 Aug; 42(8):730-41. PubMed ID: 22723667
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and therapy of GIST].
Helmberger T
Radiologe; 2009 Dec; 49(12):1103. PubMed ID: 20012259
[No Abstract] [Full Text] [Related]
10. Gastrointestinal stromal tumors: risk assessment and adjuvant therapy.
Joensuu H
Hematol Oncol Clin North Am; 2013 Oct; 27(5):889-904. PubMed ID: 24093166
[TBL] [Abstract][Full Text] [Related]
11. Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: validation study in multiple clinical facilities.
Kubota D; Orita H; Yoshida A; Gotoh M; Kanda T; Tsuda H; Hasegawa T; Katai H; Shimada Y; Kaneko K; Kawai A; Kondo T
Jpn J Clin Oncol; 2011 Oct; 41(10):1194-202. PubMed ID: 21903705
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal stromal tumor with dedifferentiation to undifferentiated pleomorphic sarcoma.
Jung JH; Im S; Choi HJ; Lee YS; Jung ES
Pathol Int; 2013 Sep; 63(9):479-82. PubMed ID: 24200161
[No Abstract] [Full Text] [Related]
13. Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: novel monoclonal antibody and external validation study in multiple clinical facilities.
Kikuta K; Gotoh M; Kanda T; Tochigi N; Shimoda T; Hasegawa T; Katai H; Shimada Y; Suehara Y; Kawai A; Hirohashi S; Kondo T
Jpn J Clin Oncol; 2010 Jan; 40(1):60-72. PubMed ID: 19815537
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumors (GIST).
Landi B; Bouche O; Blay JY
Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S98-2S101. PubMed ID: 17151569
[No Abstract] [Full Text] [Related]
15. Gastrointestinal stromal tumor--background, pathology, treatment.
Eisenberg BL; Pipas JM
Hematol Oncol Clin North Am; 2012 Dec; 26(6):1239-59. PubMed ID: 23116579
[TBL] [Abstract][Full Text] [Related]
16. New developments in gastrointestinal stromal tumor.
Trent JC; Benjamin RS
Curr Opin Oncol; 2006 Jul; 18(4):386-95. PubMed ID: 16721136
[TBL] [Abstract][Full Text] [Related]
17. High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.
Stacchiotti S; Collini P; Messina A; Morosi C; Barisella M; Bertulli R; Piovesan C; Dileo P; Torri V; Gronchi A; Casali PG
Radiology; 2009 May; 251(2):447-56. PubMed ID: 19261927
[TBL] [Abstract][Full Text] [Related]
18. NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines.
Demetri GD; Benjamin R; Blanke CD; Choi H; Corless C; DeMatteo RP; Eisenberg BL; Fletcher CD; Maki RG; Rubin BP; Van den Abbeele AD; von Mehren M;
J Natl Compr Canc Netw; 2004 May; 2 Suppl 1():S-1-26; quiz 27-30. PubMed ID: 23573667
[TBL] [Abstract][Full Text] [Related]
19. NCCN Task Force report: gastrointestinal stromal tumor (GIST).
Demetri G; DeMatteo RP
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-25-8. PubMed ID: 23570095
[No Abstract] [Full Text] [Related]
20. A multidisciplinary approach to the diagnosis and treatment of gastrointestinal stromal tumor.
Mullady DK; Tan BR
J Clin Gastroenterol; 2013 Aug; 47(7):578-85. PubMed ID: 23751846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]